4174 related articles for article (PubMed ID: 6219841)
41. Associated expression of HLA class I and class II antigens on melanoma cells in surgically removed metastases.
van Duinen SG; Ruitter DJ; Ferrone S
J Pathol; 1986 Aug; 149(4):339-48. PubMed ID: 3531448
[TBL] [Abstract][Full Text] [Related]
42. Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients.
Valmori D; Liénard D; Waanders G; Rimoldi D; Cerottini JC; Romero P
Cancer Res; 1997 Feb; 57(4):735-41. PubMed ID: 9044853
[TBL] [Abstract][Full Text] [Related]
43. Immunophenotypic characterization of human primary and metastatic melanoma infiltrating leukocytes.
Bodey B; Bodey B; Siegel SE; Luck JV; Kaiser HE
Anticancer Res; 1996; 16(6B):3439-46. PubMed ID: 9042204
[TBL] [Abstract][Full Text] [Related]
44. Immunophenotypically varied cell subpopulations in primary and metastatic human melanomas. Monoclonal antibodies for diagnosis, detection of neoplastic progression and receptor directed immunotherapy.
Bodey B; Kaiser HE; Goldfarb RH
Anticancer Res; 1996; 16(1):517-31. PubMed ID: 8615665
[TBL] [Abstract][Full Text] [Related]
45. Current research on immunopathology of melanoma: analysis of lymphocyte populations in relation to antigen expression and histological features of melanoma.
Hersey P; Murray E; Grace J; McCarthy WH
Pathology; 1985 Jul; 17(3):385-91. PubMed ID: 2866482
[TBL] [Abstract][Full Text] [Related]
46. Immunohistological evaluation of MHC class I and II antigen expression on nevi and melanoma: relation to biology of melanoma.
D'Alessandro G; Zardawi I; Grace J; McCarthy WH; Hersey P
Pathology; 1987 Oct; 19(4):339-46. PubMed ID: 3328139
[TBL] [Abstract][Full Text] [Related]
47. Direct costimulation of tumor-reactive CTL by helper T cells potentiate their proliferation, survival, and effector function.
Giuntoli RL; Lu J; Kobayashi H; Kennedy R; Celis E
Clin Cancer Res; 2002 Mar; 8(3):922-31. PubMed ID: 11895927
[TBL] [Abstract][Full Text] [Related]
48. [Autologous mixed lymphocyte culture (AMLC)].
Volk HD; Grunow R
Allerg Immunol (Leipz); 1984; 30(2):60-73. PubMed ID: 6237558
[TBL] [Abstract][Full Text] [Related]
49. HLA-DR antigen expression in primary melanomas of the skin.
Bröcker EB; Suter L; Sorg C
J Invest Dermatol; 1984 Mar; 82(3):244-7. PubMed ID: 6366074
[TBL] [Abstract][Full Text] [Related]
50. Tumor-reactive T helper lymphocytes recognize a promiscuous MAGE-A3 epitope presented by various major histocompatibility complex class II alleles.
Kobayashi H; Song Y; Hoon DS; Appella E; Celis E
Cancer Res; 2001 Jun; 61(12):4773-8. PubMed ID: 11406551
[TBL] [Abstract][Full Text] [Related]
51. Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease.
Whitwell HL; Hughes HP; Moore M; Ahmed A
Br J Cancer; 1984 Feb; 49(2):161-72. PubMed ID: 6365133
[TBL] [Abstract][Full Text] [Related]
52. [Expression of HLA-class II antigens in malignant melanoma].
Nakamura T; Matsuno M; Kageshita T; Arao T
Nihon Hifuka Gakkai Zasshi; 1990 Jan; 100(1):49-56. PubMed ID: 2191157
[TBL] [Abstract][Full Text] [Related]
53. Distribution of non-lymphoid, inflammatory cells in chronic HBV infection.
van den Oord JJ; De Vos R; Facchetti F; Delabie J; De Wolf-Peeters C; Desmet VJ
J Pathol; 1990 Mar; 160(3):223-30. PubMed ID: 2139889
[TBL] [Abstract][Full Text] [Related]
54. Distribution of histocompatibility and leucocyte differentiation antigens in normal human colon and in benign and malignant colonic neoplasms.
Csiba A; Whitwell HL; Moore M
Br J Cancer; 1984 Nov; 50(5):699-709. PubMed ID: 6238615
[TBL] [Abstract][Full Text] [Related]
55. Analysis of lymphocytic infiltration in uveal melanoma.
Durie FH; Campbell AM; Lee WR; Damato BE
Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):2106-10. PubMed ID: 2211008
[TBL] [Abstract][Full Text] [Related]
56. [Parapsoriasis en plaques. Characterization of the cellular infiltrate using monoclonal antibodies].
Büchner SA
Z Hautkr; 1988 May; 63(5):423-4, 427-9. PubMed ID: 3043952
[TBL] [Abstract][Full Text] [Related]
57. HLA-Dr+ T cells of the Leu 3 (helper) type infiltrate the kidneys of patients with systemic lupus erythematosus.
Caligaris-Cappio F; Bergui L; Tesio L; Ziano R; Camussi G
Clin Exp Immunol; 1985 Jan; 59(1):185-9. PubMed ID: 3156013
[TBL] [Abstract][Full Text] [Related]
58. Association between natural killer cells and regression in melanocytic lesions.
McKay K; Moore PC; Smoller BR; Hiatt KM
Hum Pathol; 2011 Dec; 42(12):1960-4. PubMed ID: 21676435
[TBL] [Abstract][Full Text] [Related]
59. Immunohistological analysis of the lymphoid infiltrate in cutaneous malignant melanomas.
Ralfkiaer E; Hou-Jensen K; Gatter KC; Drzewiecki KT; Mason DY
Virchows Arch A Pathol Anat Histopathol; 1987; 410(4):355-61. PubMed ID: 3101284
[TBL] [Abstract][Full Text] [Related]
60. [Immune status of patients with malignant melanoma during combined therapy including local ultra-high frequency hyperthermia].
Risina DIa; Zhakov IG; Fradkin SZ; Zhabrid EA
Vopr Onkol; 1989; 35(12):1437-40. PubMed ID: 2532801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
